These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21165998)
1. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer. Strasberg SM; Dehdashti F J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998 [TBL] [Abstract][Full Text] [Related]
2. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. Ruers TJ; Wiering B; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Krabbe PF; Oyen WJ J Nucl Med; 2009 Jul; 50(7):1036-41. PubMed ID: 19525451 [TBL] [Abstract][Full Text] [Related]
3. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241 [TBL] [Abstract][Full Text] [Related]
4. FDG-PET for the pre-operative evaluation of colorectal liver metastases. Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310 [TBL] [Abstract][Full Text] [Related]
5. The role of FDG-PET in the selection of patients with colorectal liver metastases. Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488 [TBL] [Abstract][Full Text] [Related]
6. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615 [TBL] [Abstract][Full Text] [Related]
7. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565 [TBL] [Abstract][Full Text] [Related]
8. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases. Zubeldia JM; Bednarczyk EM; Baker JG; Nabi HA Cancer Biother Radiopharm; 2005 Aug; 20(4):450-6. PubMed ID: 16114993 [TBL] [Abstract][Full Text] [Related]
9. Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET. Finkelstein SE; Fernandez FG; Dehdashti F; Siegel BA; Hawkins WG; Linehan DC; Strasberg SM J Hepatobiliary Pancreat Surg; 2008; 15(5):483-7. PubMed ID: 18836801 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996 [TBL] [Abstract][Full Text] [Related]
11. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer. Laurens ST; Oyen WJ PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671 [TBL] [Abstract][Full Text] [Related]
12. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. Zealley IA; Skehan SJ; Rawlinson J; Coates G; Nahmias C; Somers S Radiographics; 2001 Oct; 21 Spec No():S55-69. PubMed ID: 11598248 [TBL] [Abstract][Full Text] [Related]
13. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Huguet EL; Old S; Praseedom RK; Balan KK; Gibbs P; Jamieson NV Hepatogastroenterology; 2007 Sep; 54(78):1667-71. PubMed ID: 18019690 [TBL] [Abstract][Full Text] [Related]
14. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Fong Y; Saldinger PF; Akhurst T; Macapinlac H; Yeung H; Finn RD; Cohen A; Kemeny N; Blumgart LH; Larson SM Am J Surg; 1999 Oct; 178(4):282-7. PubMed ID: 10587184 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966 [TBL] [Abstract][Full Text] [Related]
16. Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer. McLeish AR; Lee ST; Byrne AJ; Scott AM ANZ J Surg; 2012; 82(1-2):30-5. PubMed ID: 22507492 [TBL] [Abstract][Full Text] [Related]
17. Survival of patients staged by FDG-PET before resection of hepatic metastases from colorectal cancer. Strasberg SM; Siegal BA Ann Surg; 2002 Feb; 235(2):308; author reply 310. PubMed ID: 11807374 [No Abstract] [Full Text] [Related]
18. FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study. Sørensen M; Mortensen FV; Høyer M; Vilstrup H; Keiding S; Scand J Surg; 2007; 96(3):209-13. PubMed ID: 17966746 [TBL] [Abstract][Full Text] [Related]
19. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Wiering B; Ruers TJ; Oyen WJ Expert Rev Anticancer Ther; 2004 Aug; 4(4):607-13. PubMed ID: 15270664 [TBL] [Abstract][Full Text] [Related]
20. PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases. Jones C; Badger SA; McKie LD; Diamond T; Taylor MA; Lynch TB Eur J Surg Oncol; 2012 Dec; 38(12):1184-8. PubMed ID: 22883963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]